Exosomal circSHKBP1 participates in non-small cell lung cancer progression through PKM2-mediated glycolysis
Wenbiao Chen, Donge Tang, Junqi Lin, Xiaoming Huang, Shaoming Lin, Guanle Shen, Yong Dai
Journal：Molecular Therapy-Oncolytics
IF：6.31
DOI：10.1016/j.omto.2022.01.012
PMID：35229026
Published：2022-02-02
research field：肿瘤学癌症代谢分子生物学微生物组研究感染性微生物与癌症
Abstract
Non-small cell lung cancer (NSCLC) has a high morbidity and mortality, and it is imperative to explore the latent pathogenesis mechanism of NSCLC progression to find potential prognostic biomarkers and therapeutic targets. The present study aimed to explore the biological function of circSHKBP1 in NSCLC. circSHKBP1 was found to be upregulated in NSCLC tissues and cell lines and was enriched in exosomes derived from NSCLC cells. Exosomal circSHKBP1 enhanced the proliferation, migration, invasion, and stemness of NSCLC cells. miRNA-1294 was identified as a target for circSHKBP1, and circSHKBP1 upregulated PKM2 expression by sponging miR-1294. Exosomal circSHKBP1 regulated glycolysis through PKM2 in a HIF-1α-dependent manner in NSCLC cells and promoted M2 polarization and macrophage recruitment. Moreover, exosomal circSHKBP1 promoted NSCLC cell growth, metastasis, and M2 infiltration in vivo . Thus, exosomal circSHKBP1 participated in the progression of NSCLC via the miR-1294/PKM2 axis. circSHKBP1 may be potential biomarker for the diagnosis and treatment of NSCLC.
本文使用的Yeasen产品
